Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma

Overview of attention for article published in Journal of Bone and Mineral Metabolism, October 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 12,432 followers.

Zoledronic acid use and skeletal-related events was associated with a decreased risk of SRE for patients with SRE history in patients with bone metastatic cancer or multiple myeloma in Korean cohort. Jeon HL et al. J Bone Miner Metab. 2019 Oct 31 https:

13 Nov 2019

Reply Repost Favourite

RT @EagleMyeloma: Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma. Hardening your b…

04 Nov 2019

Reply Repost Favourite

RT @EagleMyeloma: Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma. Hardening your b…

03 Nov 2019

Reply Repost Favourite

RT @EagleMyeloma: Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma. Hardening your b…

02 Nov 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.